Effect of 1PC111, a Fixed-dose Combination of Pitavastatin and Ezetimibe, Versus Pitavastatin or Ezetimibe Monotherapy on Lipid Profiles in Patients With Hypercholesterolemia or Mixed Dyslipidemia: A Randomized, Double-blind, Multicenter, Phase III Study-Reference-Cited by-同舟云学术

Effect of 1PC111, a Fixed-dose Combination of Pitavastatin and Ezetimibe, Versus Pitavastatin or Ezetimibe Monotherapy on Lipid Profiles in Patients With Hypercholesterolemia or Mixed Dyslipidemia: A Randomized, Double-blind, Multicenter, Phase III Study

Published:2022-10 Issue:10 Volume:44 Page:1272-1281
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Chou Ming-Ting,McGirr Anthony,Jong Gwo-Ping,Chao Ting-Hsing,Lee I-Te,Huang Chun-Yao,Chen Ching-Pei,Hsieh Chang-Hsun,Lu Chieh-Hsiang,Sheu Wayne Huey-Herng^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference20 articles.

1. Dyslipidemia and risk of cardiovascular events in patients with atrial fibrillation treated with oral anticoagulation therapy: insights from the ARISTOTLE (apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation) trial;Pol;J Am Heart Assoc,2018

2. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia;Shepherd;N Engl J Med,1995

3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

4. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur Heart J,2017

5. Pitavastatin: an overview;Saito;Atheroscler Suppl,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Pitavastatin/Ezetimibe Fixed-Dose Combination vs. Pitavastatin: Phase III, Double-Blind, Randomized Controlled Trial;Journal of Atherosclerosis and Thrombosis;2023-11-01

2. Long-term Efficacy and Safety of K-924 Pitavastatin/Ezetimibe Fixed-dose Combination in Patients with Hypercholesterolemia: A Phase III, Multi-center, Open-label Trial;Journal of Atherosclerosis and Thrombosis;2023

3. Dual Therapy for Dyslipidemia: When Two May Be Better Than One;Clinical Therapeutics;2022-10